long-acting interferon drug product company in Hepatitis and Cytokines

Home / Product Category / Drug Products / Pegsomatropin Injection / Pegsomatropin Injection

Pegsomatropin Injection


Strength:	2.5mg / 0.35mL solution in a single-dose prefilled syringe 3.0mg / 0.35mL solution in a single-dose prefilled syringe 3.5mg / 0.35mL solution in a single-dose prefilled syringe 5.0mg / 0.5mL solution in a single-dose prefilled syringe 2.0mg / 0.5mL solution in a single-dose vial
Availability:

Quantity:



Inquire Add to Basket

Trade Name: Pegpesen^?
Generic Name: Inpegsomatropin Injection（Pegylated growth hormone）

Product Description

Brief Introduction:

Launched in 2025
National Class 1 New Biological Product
The first 40kD Y-shape branched PEG modified long-acting growth hormone injection in the World.
Brand new International Nonproprietary Name approved by WHO.

Indications:

Inpegsomatropin is indicated for the treatment of growth failure in children aged 3 and older due to growth hormone deficiency (GHD).

Related News

content is empty!

WELCOME

Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..

Fax: +86-592-6889110???????
international@tzlccs.com???????
Tel: +86-592-6889106

Leave a Message